Assessment TaskStudents are required to individually choose one aim from one grant scenarios.Grant scenarios:• Anti-integrin therapy to dampen inflammation and reduce scar formation?• Iscomatrix as a vaccine adjuvant to protect against genital tract chlamydial infectionsOral Presentation: As a group students need to prepare a 3 minute introduction with visual aids forthe grant proposal (as a group nominate one member to present) outlining the background andsignificance of their grant proposal. For each aim in the proposal, each student will present a short5 min presentation with visual aids outlining the background scientific information relating to theaim and the experimental design proposed to answer the aim. This will include ethicalconsiderations, experimental controls and equipment required for the planned experiment.Following your oral presentation, the review panel will ask questions on your experimental rationaleand provide comments on your proposal and presentation.Group work: Each student will fill out a group work survey rating their own (space 1) and the othergroup member participation and submit to AIC following presentations.Referencing: Only references from refereed journals may be cited. Material from textbooks, reviewsand web pages cannot be cited although they may provide very helpful background information tohelp you get a feel for your topic. Special care should be taken to ensure that references refer tothe original report of the fact being reported. You are reminded that information found in theIntroduction section of a scientific paper is NOT derived from that paper but from earlier work.There is no minimum or maximum reference list.Project AimsAim 1: Identify the immune specific integrins expressed on the surface of blood-derivedmonocytes isolated from normal and burn patient patient blood in vitro.Aim 2: Determine the immune specific integrins associated with migration of humanmonocytes isolated from normal and burn patient paitent blood through the endothelium invitro.Aim 3: Determine if early Scarless treatment reduce scarring outcomes in a mouse burnwound mode in vivo.Aim 4: Using specific function-blocking integrin antibodies (identified in aim 2) determine themechanisms used by scarless in vivo to improve healing and reduce scar formation.
Already registered? Login
Not Account? Sign up
Enter your email address to reset your password
Back to Login? Click here